Abstract
AbstractBackgroundCysteamine was coated to cover its odor and maintain the stability. However, coated cysteamine (CC) has not been clearly evaluated for its effects on the gastrointestinal mucosa status. We hypothesize that the appropriate CC supplementation in diet impacts the stomach and intestinal mucosa variously through regulating the morphology, apoptosis, and oxidative stress status in model of pigs.ResultsThe results showed that villus height increased (P < 0.05), and crypt depth decreased (P < 0.05) in the ileum when pigs were fed the diet with low cysteamine (LCS) compared with the control diet. The ileal lesion score in the LCS group was significantly (P < 0.01) lower than that in the control group, while the gastric lesion score in the CC group was significantly (P < 0.01) higher compared with that of the control group. It also showed that the activities of total superoxide dismutase (T-SOD) and diamine oxidase (DAO) were upregulated (P < 0.05) in the LCS group. In addition, Bax and caspase 3 immunore-activity increased (P < 0.01), and Bcl-2 immunoreactivity decreased (P < 0.01) in the gastric mucosa of pigs fed the diet with high cysteamine (HCS). The Bax and caspase 3 immunoreactivity decreased (P < 0.01), and Bcl-2 immunoreactivity increased (P < 0.01) in ileum mucosa of pigs fed the HCS diet.ConclusionsAlthough moderate dietary coated cysteamine showed positive effects on GI mucosal morphology, apoptosis, and oxidative stress status, the excess coated cysteamine may cause apoptosis leading to GI damage in pigs.
Funder
National Basic Research Program of China (973 Program)
Natural Science Foundation of Hunan Province of China
Youth Talent Program of Hunan Province
Youth Innovation Promotion Association of the Chinese Academy of Sciences
China Agriculture Research System
Youth Innovation Team Project of ISA, CAS
Publisher
Springer Science and Business Media LLC
Subject
General Veterinary,General Medicine
Reference38 articles.
1. Kleta R, Gahl WA. Pharmacological treatment of nephropathic cystinosis with cysteamine. Expert Opin Pharmacother. 2004;5(11):2255–62.
2. Wühl E, Haffner D, Offner G, Broyer M, van’t Hoff W, Mehls O. Cystinosis ESGoGHTiCwN: Long-term treatment with growth hormone in short children with nephropathic cystinosis. J Pediatr. 2001;138(6):880–7.
3. Kimonis VE, Troendle J, Rose SR, Yang ML, Markello TC, Gahl WA. Effects of early cysteamine therapy on thyroid function and growth in nephropathic cystinosis. J Clin Endocrinol Metab. 1995;80(11):3257–61.
4. Yang CB, Li AK, Yin YL, Huang RL, Li TJ, Li LL, Liao YP, Deng ZY, Zhang J, Wang B. Effects of dietary supplementation of cysteamine on growth performance, carcass quality, serum hormones and gastric ulcer in finishing pigs. J Sci Food Agric. 2005;85(11):1947–52.
5. Liu G, Wei Y, Wang Z, Wu D, Zhou A. Effects of dietary supplementation with cysteamine on growth hormone receptor and insulin-like growth factor system in finishing pigs. J Agric Food Chem. 2008;56(13):5422–7.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献